These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 15619780)

  • 1. Editorial comment: reversing lipoatrophy--better solutions needed.
    McComsey G
    AIDS Read; 2004 Dec; 14(12):648-9. PubMed ID: 15619780
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipodystrophy update--the continuing saga.
    Proj Inf Perspect; 2001 Mar; (32):9-10. PubMed ID: 11682779
    [No Abstract]   [Full Text] [Related]  

  • 3. Face to face with lipoatrophy. An interview with David Nolan by Nelson Vergel.
    Nolan D
    GMHC Treat Issues; 2005; 19(3-4):1-6. PubMed ID: 16003843
    [No Abstract]   [Full Text] [Related]  

  • 4. Lipodystrophy update.
    Proj Inf Perspect; 2002 Mar; (34):7-8. PubMed ID: 12038302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-associated lipodystrophy syndrome.
    Mauss S
    AIDS; 2000; 14 Suppl 3():S197-207. PubMed ID: 11086863
    [No Abstract]   [Full Text] [Related]  

  • 6. Management options for facial lipoatrophy.
    Cofrancesco J; Brown T; Martins CR
    AIDS Read; 2004 Dec; 14(12):639-40, 645-50. PubMed ID: 15619779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoatrophy: a new "scarlet letter".
    Hoyt G
    Surviv News (Atlanta Ga); 2004; 15(2):8, 19. PubMed ID: 15124576
    [No Abstract]   [Full Text] [Related]  

  • 8. Complications & side effects. Nukes and fat wasting.
    TreatmentUpdate; 2004; 16(7):3-4. PubMed ID: 17225282
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-HIV agents. Leading to lipodystrophy.
    TreatmentUpdate; 2007 Feb; 19(2):3-4. PubMed ID: 17447312
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial comment: tenofovir nephrotoxicity--vigilance required.
    Fine DM
    AIDS Read; 2005 Jul; 15(7):362-3. PubMed ID: 16044578
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of zidovudine in development of lipoatrophy.
    Moyle GJ
    AIDS Read; 2005 Nov; 15(11):591-4, 599-600, 603. PubMed ID: 16329181
    [No Abstract]   [Full Text] [Related]  

  • 12. Is there a relationship between hepatitis C virus infection and antiretroviral-associated lipoatrophy?
    Zylberberg H; Nalpas B; Pol S; Bréchot C; Viard JP
    AIDS; 2000 Sep; 14(13):2055. PubMed ID: 10997414
    [No Abstract]   [Full Text] [Related]  

  • 13. Non-nucleoside-reverse-transcriptase-inhibitor-based HAART and osteoporosis in HIV-infected subjects.
    Bongiovanni M; Fausto A; Cicconi P; Aliprandi A; Cornalba G; Bini T; Sardanelli F; D'Arminio Monforte A
    J Antimicrob Chemother; 2006 Aug; 58(2):485-6. PubMed ID: 16751202
    [No Abstract]   [Full Text] [Related]  

  • 14. Report from the 12th Retrovirus Conference. Metabolic complications.
    Henry K
    AIDS Clin Care; 2005 Apr; 17(4):37-8. PubMed ID: 15875312
    [No Abstract]   [Full Text] [Related]  

  • 15. Meeting report from the XV International AIDS Conference. Metabolic complications.
    Currier J
    AIDS Clin Care; 2004 Sep; 16(9):73-4. PubMed ID: 15540318
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial comment: a plethora or options in multidrug-resistant HIV-1 infection.
    Katzenstein DA
    AIDS Read; 2008 Sep; 18(9):478-9. PubMed ID: 18828232
    [No Abstract]   [Full Text] [Related]  

  • 17. It's time to face the Zerit problem.
    Vergel N
    GMHC Treat Issues; 2003 Mar; 17(3):12. PubMed ID: 12728861
    [No Abstract]   [Full Text] [Related]  

  • 18. Fat loss prompts SA treatment switch.
    IAPAC Mon; 2006 Jul; 12(7):212. PubMed ID: 17096492
    [No Abstract]   [Full Text] [Related]  

  • 19. Practical management of lipid abnormalities in HIV--case studies.
    Peters BS
    Int J STD AIDS; 2005 Oct; 16 Suppl 1():31-3; discussion 33-4, 41-3. PubMed ID: 16238829
    [No Abstract]   [Full Text] [Related]  

  • 20. A review of the aetiology of dyslipidaemia and hyperlipidaemia in patients with HIV.
    Moyle G
    Int J STD AIDS; 2005 Oct; 16 Suppl 1():14-20; discussion 20-2, 41-3. PubMed ID: 16238827
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.